DUKE UNIVERSITY
SCHOOL OF MEDICINE
DUKEHEALTH.ORG
Institutional Review Board
irb.mc.duke.edu
School of Medicine
»
Institutional Review Board
»
HRPP Policies
» HRPP Policies and Procedures
Jump to Main Content
General Information
About the Department
Staff Contacts
News
For DUHS Researchers
e-IRB
Forms
/S
tandar
d L
anguage
HRPP Policies
Federal Regulations
Federa
l W
id
e
Assurance
Fees
Compliance Statement
FAQs
Online Resources
Educational Resources
Secondary Navigation:
Contact Us
How to Find Us
Site Map
Secondary Navigation:
IRB Members Log In
For the Public & Participants
Information About Participating in Clinical Trials at Duke
Research participants may
Contact Us
with questions or concerns.
Educational Opportunities
Training and Continuing Education Opportunities Offered Through the
DOCR
OHRP Powerpoint Presentations
Top Ten Investigator Responsibilities
IRB Review
OHRP Compliance
Convened IRBs
Meeting Dates for 2013
Meeting Dates for 2014
Current IRB Roster
of All Members
IRB Rosters for Each Board
Archive of Past IRB Rosters
IRB Certifications
Requirements for Human Subjects Protection Certification for Duke Researchers
CITI Web Site
- Navigate to this site to complete your Human Subjects Protection Certification
HRPP Policies
Duke Medicine Human Research Protection Program
Policies and Procedures
Recruitment, Ascertainment and Advertising
Advertisement of Research Studies
Processing Payments to Research Participants
Recruitment of Other People's Patients
Recruitment of Students and Employees
Review of an Investigator's Request for a Waiver of Selected Inclusion/Exclusion Criteria for a Single Person
Informed Consent
Consent Monitoring
Informed Consent and Its Documentation
IRB Approval Stamp on Consent Forms
Research Involving Non-English-Speaking Subjects
Use of the Legally Authorized Representative in Research
(Revised Policy Posted on 6-15-2012)
Use of the Short Form Consent Document
Waiver of Documentation of Consent
Conflict of Interest (COI)
Conflict of Interest Pertaining to DUHS IRB Members and Consultants
(Revised Policy Posted on 12-10-2011)
Corrective Actions Declared by the DUSOM Conflict of Interest Committee
(Revised Policy Posted on 7-11-2012)
Telephone Scripts/Research via Telephone, Mail or e-Mail
Suggested Format and Content for Telephone Scripts
Use of Questionnaires by Telephone or Mail
IRB Review
Allegations of Undue Influence Upon the DUHS IRB
Amendments to IRB-Approved Studies
(Revised Policy Posted on 12-10-2011)
Assessing the Data and Safety Monitoring Plan
Assessing the Scientific or Scholarly Validity of a Research Protocol
Assuring Key Personnel Qualifications
(Revised Policy Posted on 7-11-2012)
Case Reports
Conduct of a Convened IRB Meeting
(Revised Policy Posted on 7-26-2011)
Continuing Review
(Revised Policy Posted on 12-11-2011)
Declarations of Concordance
Determining the Frequency of Continuing Review
Determining Which Studies Need Verification from Sources Other than the Investigator
Emergency Use
(Revised Policy Posted on 12-11-2011)
Expedited Review
(Revised Policy Posted on 12-11-2011)
Institutional Oversight of Human Research
IRB Fees
IRB Interaction with Compliance Offices
(Revised Policy Posted on 12-11-2011)
IRB Membership, Voting and Quorum
(Revised Policy Posted on 12-11-2011)
IRB Minutes
(Revised Policy Posted on 1-13-2012)
IRB Processing of Modifications
(Revised Policy Posted on 12-11-2011)
Legal Counsel Opinion Policy
Nomination of New IRB Members and Evaluation of Members
(Revised Policy Posted on 12-11-2011)
Quality Improvement (QI) Activities vs. Research
(Revised Policy Posted on 4-30-2013)
Research for Which Review by the DUHS HRPP Is Required (includes policy on V.A. research)
(Revised Policy Posted on 7-27-2012)
Retention of IRB Records and Research Records
(Revised Policy Posted on 4-18-2011)
Review and Approval by Other (Specialty) Committees
(Revised Policy Posted on 12-11-2011)
Review and Processing of Problems, Complaints, Concerns, and Questions from Research Subjects
(Revised Policy Posted on 12-11-2011)
Role of the Institutional Official (IO)
Use of Consultants in IRB Review
Veterans Administration (V.A.) Research Involving Human Subjects
Databases/Repositories and Retrospective Research Including Specimens
Data Use Agreements
(See the Attachments at the end of the policy)
Research Databases, Specimen Repositories and Contact Lists
(Revised Policy Posted on 7-9-2010)
Research Using Coded Specimens or Coded Private Information
Use of Existing Data or Specimens in Retrospective Research
Use of Duke Data by Former Students & Employees
External Use of Duke Data by Former Students & Employees
(NEW -- Posted on 3-11-2013)
Conduct of Research
Administration of a Study Drug or Study Procedure by a Research Participant's Local Physician
("Agents" policy)
Autopsy Authorizations
Blood Drawing for Human Subject Research
(Revised Policy Posted on 12-13-2012)
Certificates of Confidentiality
Compensation and Payment for Research Participation
Contraceptive Use
Department of Defense (DoD)-Sponsored Research: Requirements
(Revised Policy Posted on 6-5-2011)
Department of Education-Sponsored Research: Requirements
Determining if Research is Subject to or Exempt from the Privacy Rule (HIPAA)
Duke Trainees (Medical Students & Others) Engaged in Research Involving Human Subjects at a Site Other Than Within DUHS
(Revised Policy Posted on 4-17-2013)
HIPAA as it Relates to Research
Injury Compensation for Research Participants
International Research
Investigator Concerns
(Revised Policy Posted on 12-11-2011)
Pregnancy Testing
(Revised Policy Posted on 1-14-2013)
Reliance on the IRB of Another Institution, Organization, or an Independent IRB
(Revised Policy Posted on 5-4-2011)
Required Education on Protection of Human Subjects
Research by Faculty or Staff Away From Duke
(Revised Policy Posted on 12-11-2011)
Research Involving Multiple Sites
(Revised Policy Posted on 7-11-2012)
Research Involving the Use of Thalidomide, Lenalidomide or Analogs Thereof
Tissue/
Specimens that May Be Excluded from Routine Submission to Surgical Pathology
and the PATHOLOGY TISSUE/SPECIMEN EXEMPTION LIST
(behind the Duke firewall)
Use of Gadolinium-Based Contrast Agents in Research
Who May Serve as a Principal Investigator in the DUHS HRPP
(Updated Policy Posted on 7-12-2011)
Research Involving Drugs, Devices or Biologics
Humanitarian Use Devices and Their Review
(Revised Policy Posted on 12-09-2010)
In Vitro Diagnostic Device Studies - FDA Enforcement Discretion
Research Involving Drugs, Biologics or Devices
(Revised Policy Posted on 12-11-2011)
Responsibilities of an Investigator Who Is Also a Sponsor
(Revised Policy Posted on 12-11-2011)
Significant Risk/Non-Significant Risk Device Determinations by the IRB
Use of Pharmacy Investigational Drug Service (IDS)
Vulnerable Populations in Research
Assessment of Decision Making Capacity in Adult Research Participants
(Revised Policy Posted on 12-11-2011)
Determination of Risk in Studies Involving Children
(Revised Policy Posted on 5-31-2011)
Research Involving Children
Research Involving Children Who are Wards of the State
Research Involving Pregnant Women
Research Involving Prisoners
Reporting to the IRB
Prompt Reporting of Unanticipated Problems
(Revised Policy Posted on 7-19-2011)
Reporting of Protocol Deviations/Violations
Regulatory Compliance
Expiration of IRB Approval and Closing Reports
(Revised Policy Posted on 2-2-2011)
Holds, Suspensions and Terminations
(Revised Policy Posted on 5-31-2011)
Noncompliance Policy
(Revised Policy Posted on 5-20-2011)
Reporting IRB Findings to DUHS Officials and Federal Regulatory Agencies
State Law Considerations
Mandatory State Reporting Requirements
State Law as it Relates to Research
© 2013, Duke University Health System
DHTS Web Services